An integrin α4β7•IgG heterodimeric chimera binds to MAdCAM-1 on high endothelial venules in gut-associated lymphoid tissue

Journal of Histochemistry and Cytochemistry

Volumn 59, Issue 6, 2011, Pages 572-583

  Hoshino, Hitomi ^a,b   Kobayashi, Motohiro ^a   Mitoma, Junya ^c   Sato, Yoshiko ^a   Fukuda, Minoru ^d   Nakayama, Jun ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^d BURNHAM INSTITUTE   (United States)

Author keywords

4 7 integrin; Functional probe; Gut associated lymphoid tissue (galt); High endothelial venule (hev); Lymphocyte homing; Mucosal addressin cell adhesion molecule 1 (madcam 1)

Indexed keywords

ALPHA 4 BETA 7 INTEGRIN IMMUNOGLOBULIN G; ALPHA4 INTEGRIN; BETA7 INTEGRIN; DIVALENT CATION; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CELL ADHESION MOLECULE; IMMUNOGLOBULIN; INTEGRIN; INTEGRIN ALPHA4BETA7; MADCAM1 PROTEIN, HUMAN; MADCAM1 PROTEIN, MOUSE; MUCOPROTEIN; PRIMER DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CHIMERA; CHO CELL; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM; EXPRESSION VECTOR; EXTRACELLULAR SPACE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; VENULE; WESTERN BLOTTING; ANIMAL; CELL LINE; CRICETULUS; DIMERIZATION; HAMSTER; LYMPHOID TISSUE; METABOLISM; NUCLEOTIDE SEQUENCE; VASCULARIZATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DIMERIZATION; DNA PRIMERS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; INTEGRINS; LYMPHOID TISSUE; MICE; MUCOPROTEINS; VENULES;

EID: 79960924016     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155411404416     Document Type: Article

References (39)

1. Aarden L, Ruuls SR, Wolbink G. 2008. Immunogenicity of antitumor necrosis factor antibodies: toward improved methods of anti-antibody measurement. Curr Opin Immunol. 20:431-435.
2. Andrew DP, Berlin C, Honda S, Yoshino T, Hamann A, Holzmann B, Kilshaw PJ, Butcher EC. 1994. Distinct but overlapping epitopes are involved in a4ß7-mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin, and lymphocyte aggregation. J Immunol. 153:3847-3861.
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
4. Bergeron E, Basak A, Decroly E, Seidah NG. 2003. Processing of a4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage. Biochem J. 373:475-484.
5. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC. 1995. a4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80:413-422.
6. Butcher EC, Picker LJ. 1996. Lymphocyte homing and homeostasis. Science. 572:60-66.
7. Coe AP, Askari JA, Kline AD, Robinson MK, Kirby H, Stephens PE, Humphries MJ. 2001. Generation of a minimal a5ß1 integrin- Fc fragment. J Biol Chem. 276:35854-35866.
8. Corr SC, Gahan CC, Hill C. 2008. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol. 52:2-12.
9. Feagan BG, Greenberg GR, Wild G, Fedorak RN, Pare P, McDonald JW, Dube R, Cohen A, Steinhart AH, Landau S, et al. 2005. Treatment of ulcerative colitis with a humanized antibody to the a4ß7 integrin. N Engl J Med. 352:2499-2507.
10. Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnalek P, Zadorova Z, Palmer T, Donoghue S. 2003. Natalizumab for active Crohn's disease. N Engl J Med. 348:24-32.
11. Gordon FH, Hamilton MI, Donoghue S, Greenlees C, Palmer T, Rowley-Jones D, Dhillon AP, Amlot PL, Pounder RE. 2002. A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to a4 integrin. Aliment Pharmacol Ther. 16:699-705.
12. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A. 95:258-263.
13. Higuchi R, Krummel B, Saiki RK. 1988. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16:7351-7367.
14. Hirakawa J, Tsuboi K, Sato K, Kobayashi M, Watanabe S, Takakura A, Imai Y, Ito Y, Fukuda M, Kawashima H. 2010. Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing. J Biol Chem. 285:40864-40878.
15. Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M. 2001. Versican interacts with chemokines and modulates cellular responses. J Biol Chem. 276:5228-5234.
16. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Sitedirected mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:51-59.
17. Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673-687.
18. Kawashima H, Petryniak B, Hiraoka N, Mitoma J, Huckaby V, Nakayama J, Uchimura K, Kadomatsu K, Muramatsu T, Lowe JB, Fukuda M. 2005. N-acetylglucosamine-6-O-sulfotransferase 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat Immunol. 6:1096-1104.
19. Kobayashi M, Hoshino H, Masumoto J, Fukushima M, Suzawa K, Kageyama S, Suzuki M, Ohtani H, Fukuda M, Nakayama J. 2009. GlcNAc6ST-1-mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitis. Inflamm Bowel Dis. 15:697-706.
20. Kobayashi M, Mitoma J, Nakamura N, Katsuyama T, Nakayama J, Fukuda M. 2004. Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc Natl Acad Sci U S A. 101:17807-17812.
21. Lamagna C, Meda P, Mandicourt G, Brown J, Gilbert RJ, Jones EY, Kiefer F, Ruga P, Imhof BA, Aurrand-Lions M. 2005. Dual interaction of JAM-C with JAM-B and aMß2 integrin: function in junctional complexes and leukocyte adhesion. Mol Biol Cell. 16:4992-5003.
22. Lewinsohn DM, Bargatze RF, Butcher EC. 1987. Leukocyteendothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol. 15:4313-4321.
23. Mitoma J, Bao X, Petryanik B, Schaerli P, Gauguet JM, Yu SY, Kawashima H, Saito H, Ohtsubo K, Marth JD, et al. 2007. Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat Immunol. 8:409-418.
24. Mitoma J, Miyazaki T, Sutton-Smith M, Suzuki M, Saito H, Yeh JC, Kawano T, Hindsgaul O, Seeberger PH, Panico M, et al. 2009. The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cells. Glycoconj J. 26:511-523.
25. Nechansky A. 2010. HAHA, nothing to laugh about: measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology. J Pharm Biomed Anal. 51:252-254.
26. Pachynski RK, Wu SW, Gunn MD, Erle DJ. 1998. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin a4ß7- mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. J Immunol. 161:952-956.
27. Rosen SD. 2004. Ligand for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 22:129-156.
28. Ruegg C, Postigo AA, Sikorski EE, Butcher EC, Pytela R, Erle DJ. 1992. Role of integrin a4ß7/a4ßP in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J Cell Biol. 117:179-189.
29. Rutgeerts P, Vermeire S, Van Assche G. 2009. Biological therapies for inflammatory bowel diseases. Gastroenterology. 136:1182-1197.
30. Soler D, Chapman T, Yang LL, Wyant T, Egan R, Fedyk ER. 2009. The binding specificity and selective antagonism of vedolizumab, an anti-a4ß7 integrin therapeutic antibody in development for inflammatory bowel diseases. J Pharmacol Exp Ther. 330:864-875.
31. Stamper HB Jr., Woodruff JJ. 1976. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J Exp Med. 144:828-833.
32. Stephens PE, Ortlepp S, Perkins VC, Robinson MK, Kirby H. 2000. Expression of a soluble functional form of the integrin a4ß1 in mammalian cells. Cell Adhes Commun. 7:377-390.
33. Strauch UG, Mueller RC, Li XY, Cernadas M, Higgins JM, Binion DG, Parker CM. 2001. Integrin aE(CD103)ß7 mediates adhesion to intestinal microvascular endothelial cell lines via an E-cadherin- independent interaction. J Immunol. 166:3506-3514.
34. Streeter PR, Berg EL, Rouse BT, Bargatze RF, Butcher EC. 1988. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature. 331:41-46.
35. Suzawa K, Kobayashi M, Sakai Y, Hoshino H, Watanabe M, Harada O, Ohtani H, Fukuda M, Nakayama J. 2007. Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis. Am J Gastroenterol. 102:1499-1509.
36. Teixido J, Parker CM, Kassner PD, Hemler ME. 1992. Functional and structural analysis of VLA-4 integrin a4 subunit cleavage. J Biol Chem. 267:1786-1791.
37. Uchimura K, Gauguet JM, Singer MS, Tsay D, Kannagi R, Muramatsu T, von Andrian UH, Rosen SD. 2005. A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol. 6:1105-1113.
38. von Andrian UH, Mempel TR. 2003. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 3:867-878.
39. Watson SR, Imai Y, Fennie C, Geoffroy JS, Rosen SD, Lasky LA. 1990. A homing receptor-IgG chimera as a probe for adhesive ligands of lymph node high endothelial venules. J Cell Biol. 110:2221-2229.